Suchergebnisse - "Cil, Timucin"

PubPharm (95)

1

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Karadurmuş, N. | Ökten, �. | Türk, H. | +25

2

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC : A Phase 2 Randomized Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Vokes, E. | Mornex, F. | Sezer, A. | +17

3

The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer

enthalten in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2024

von Ata, S. | Ekici, N. | Büyükşimşek, M. | +2

4

Enteral nutrition consensus report from KEPAN : Indications, choice, practical application, and follow-up

enthalten in: Nutrition (Burbank, Los Angeles County, Calif.) | 2024

von Doganay, M. | Akcay, K. | Cil, T. | +9

5

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

enthalten in: The New England journal of medicine | 2023

von Zhou, C. | Tang, K. | Cho, B. | +126

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF9. - PMID 37878779

6

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859) : a multicentre, randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Rha, S. | Oh, D. | Yañez, P. | +121

7

Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer : A randomized, double-blind, phase III study

enthalten in: Cancer medicine | 2023

von Chen, L. | Rangel, J. | Cil, T. | +15

8

Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy

enthalten in: Medicina (Kaunas, Lithuania) | 2023

von Gulmez, A. | Coskun, H. | Koseci, T. | +3

9

Optimal use of oral nutritional supplements (ONS) in medical nutrition therapy : ONS consensus report from KEPAN

enthalten in: European journal of clinical nutrition | 2023

von Bahat, G. | Akmansu, M. | Gungor, L. | +34

10

Brigatinib-associated autoimmune hepatitis : A case report

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Buyuksimsek, M. | Ogul, A. | Yetisir, A. | +6

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]